- €1.43bn
- €3.32bn
- €3.94bn
- 90
- 96
- 88
- 100
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,740 | 2,805 | 3,123 | 3,642 | 3,937 |
Cost of Revenue | |||||
Gross Profit | 1,029 | 1,085 | 1,121 | 1,133 | 1,339 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,481 | 2,532 | 2,791 | 3,379 | 3,537 |
Operating Profit | 259 | 274 | 332 | 263 | 400 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 228 | 247 | 312 | 241 | 353 |
Provision for Income Taxes | |||||
Net Income After Taxes | 160 | 172 | 222 | 175 | 295 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 149 | 156 | 204 | 156 | 258 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 149 | 156 | 204 | 156 | 258 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.3 | 3.57 | 4.54 | 3.64 | 5.94 |
Dividends per Share |